[E 39 in therapy of chronic malignant blood diseases and other tumorous disorders; study of 100 patients].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006402:Hematologic Diseases; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use; LEUKEMIA/therapy; NEOPLASMS/therapy
Traitement par le E 39 des hémopathies malignes chroniques et d'autres affections tumorales; étude portant sur cent malades.